Case Study: Sumitovant Biopharma achieves cloud-first Zero Trust multicloud security and rapid innovation with Palo Alto Networks Network Security Platform

Innovating with a “cloud everything” strategy requires a cloud-driven security platform

Sumitovant Biopharma, a patient-first, technology-driven biopharmaceutical company pursuing a “cloud everything” strategy, needed to build a secure, multicloud network from the ground up while enabling rapid innovation and a remote workforce during the pandemic. The small IT team required consistent Zero Trust protection across AWS, Azure, and GCP, easy centralized management, fast onboarding, and audit-proof compliance without adding large engineering overhead.

To meet those needs Sumitovant deployed the Palo Alto Networks Network Security Platform — including Prisma Access, Next‑Generation Firewalls (VM‑Series and PA models), GlobalProtect, and Panorama — to provide cloud-delivered secure access and single‑pane visibility. The result was instant, consistent remote connectivity, a single global security policy, rapid onboarding (over 400 users added overnight), automatic mitigation of threats like Log4j, stronger compliance posture (SOX, JSOX, GDPR, FDA GMP, etc.), and reduced risk that lets teams innovate and scale more quickly.

Sumitovant Biopharma

Trevor Cardwell

Senior Cloud and Network Architect